Literature DB >> 17630358

Benign and malignant lesions in the human breast depicted with ultrahigh resolution and three-dimensional optical coherence tomography.

Pei-Lin Hsiung1, Darshan R Phatak, Yu Chen, Aaron D Aguirre, James G Fujimoto, James L Connolly.   

Abstract

Institutional review board approval at the participating institutions was obtained. Informed consent was waived for this HIPAA-compliant study. The study purpose was to establish the correspondence of optical coherence tomographic (OCT) image findings with histopathologic findings to understand which features characteristic of breast lesions can be visualized with OCT. Imaging was performed in 119 specimens from 35 women aged 29-81 years with 3.5-microm axial resolution and 6-microm transverse resolution at 1.1-microm wavelength on freshly excised specimens of human breast tissue. Three-dimensional imaging was performed in 43 specimens from 23 patients. Microstructure of normal breast parenchyma, including glands, lobules, and lactiferous ducts, and stromal changes associated with infiltrating cancer were visible. Fibrocystic changes and benign fibroadenomas were identified. Imaging of ductal carcinoma in situ, infiltrating cancer, and microcalcifications correlated with corresponding histopathologic findings. OCT is potentially useful for visualization of breast lesions at a resolution greater than that of currently available clinical imaging methods. Copyright (c) RSNA, 2007.

Entities:  

Mesh:

Year:  2007        PMID: 17630358     DOI: 10.1148/radiol.2443061536

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  31 in total

1.  Differentiation of ex vivo human breast tissue using polarization-sensitive optical coherence tomography.

Authors:  Fredrick A South; Eric J Chaney; Marina Marjanovic; Steven G Adie; Stephen A Boppart
Journal:  Biomed Opt Express       Date:  2014-09-04       Impact factor: 3.732

2.  Optical coherence tomography as a potential readout in clinical trials.

Authors:  Benjamin M Greenberg; Elliot Frohman
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

3.  Visualization and tissue classification of human breast cancer images using ultrahigh-resolution OCT.

Authors:  Xinwen Yao; Yu Gan; Ernest Chang; Hanina Hibshoosh; Sheldon Feldman; Christine Hendon
Journal:  Lasers Surg Med       Date:  2017-03-06       Impact factor: 4.025

4.  Comparative study of texture features in OCT images at different scales for human breast tissue classification.

Authors:  Ernest Chang; Syed Bin Amir; Hanina Hibshoosh; Sheldon Feldman; Christine P Hendon
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2016-08

5.  Rapid staining and imaging of subnuclear features to differentiate between malignant and benign breast tissues at a point-of-care setting.

Authors:  Jenna L Mueller; Jennifer E Gallagher; Rhea Chitalia; Marlee Krieger; Alaattin Erkanli; Rebecca M Willett; Joseph Geradts; Nimmi Ramanujam
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-22       Impact factor: 4.553

6.  Low coherence interferometry approach for aiding fine needle aspiration biopsies.

Authors:  Ernest W Chang; Joseph Gardecki; Martha Pitman; Eric J Wilsterman; Ankit Patel; Guillermo J Tearney; Nicusor Iftimia
Journal:  J Biomed Opt       Date:  2014       Impact factor: 3.170

7.  Assessment of breast pathologies using nonlinear microscopy.

Authors:  Yuankai K Tao; Dejun Shen; Yuri Sheikine; Osman O Ahsen; Helen H Wang; Daniel B Schmolze; Nicole B Johnson; Jeffrey S Brooker; Alex E Cable; James L Connolly; James G Fujimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

8.  Telepathology and optical biopsy.

Authors:  Olga Ferrer-Roca
Journal:  Int J Telemed Appl       Date:  2010-03-18

9.  Spectral domain optical coherence tomography for glaucoma (an AOS thesis).

Authors:  Joel S Schuman
Journal:  Trans Am Ophthalmol Soc       Date:  2008

10.  Clinical Target Volume: The Third Front.

Authors:  Leonard Kim; Cuihuan Wang; Atif Khan; Mark Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-04       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.